science top stories popular news  

Daily non-political popular news in brief.

Draft national policy on sight-saving drugs 'unacceptable'

07-02-2007 · EurekAlert!

Restricting use of drugs for macular degeneration to patients who have already gone blind in one eye is "unacceptable" concludes the July issue of Drug and Therapeutics Bulletin (DTB).But that is what the National Institute for Health and Clinical Excellence (NICE), the body responsible for guiding the NHS on which treatments to use, is proposing.

Read more »

Keywords: draft, national, policy, sight-saving, drugs, unacceptable, sight, saving, drug

« Previous | Next »

Similar news on "Draft national policy on sight-saving drugs 'unacceptable'":

  1. National experts and nonprofit organizations call to end FDA user fees and to improve drug safety
    03-14-2007 · EurekAlert!
    Opposition to current drug safety legislation is growing, as a group of 22 experts on drug safety and regulation and a coalition of 12 patient, consumer, science, and public health organizations issue two separate open letters to lawmakers. The letters asks Congress to not reauthorize the user fees legislation (PDUFA) that finances the FDA’s review of new drugs, and calls for substantial changes to drug safety legislation introduced by Senators Kennedy and Enzi.
    Similar news · Read more »
  2. No 'smoking' gun -- Research indicates teen marijuana use does not predict drug, alcohol abuse
    12-04-2006 · EurekAlert!
    Marijuana is not a "gateway" drug that predicts or eventually leads to substance abuse, suggests a 12-year University of Pittsburgh study. The study, which found that young men who chose to initiate their drug use with marijuana were no more likely to go on to abuse drugs or alcohol than those who smoked or drank first, calls into question the long-held belief that has shaped prevention efforts and governmental policy for six decades.
    Similar news · Read more »
  3. Restrictive provincial drug policies may have benefits
    12-04-2006 · EurekAlert!
    Mamdani and co-authors report on their comparison of changes over time in NSAID use and upper GI bleeding rates in British Columbia, which restricts the use of these drugs, and in Ontario, which has a less restrictive drug coverage policy. Their findings suggest that a more restrictive drug coverage policy, although limiting access to drugs and their potential benefits, may protect the population from adverse drug effects.
    Similar news · Read more »
  4. Radioactive 'understudy' may aid medical imaging, drug development
    01-09-2008 · EurekAlert!
    Broadway stars have understudies. Now, an increasingly popular radioactive isotope has its own stand-in. Developed in part by researchers at the National Institute of Standards and Technology, the substance might ultimately improve medical imaging, speed up clinical trials of many drugs and facilitate efforts to develop more individualized medical treatment.
    Similar news · Read more »
  5. A gatekeeper for the US drug industry
    03-07-2007 · EurekAlert!
    At long last, the US is considering a government body, similar to the UK's National Institute for Health and Clinical Excellence (NICE), to review evidence on which drugs work well and whether they are cost-effective. The proposed Comparative Effectiveness Board (CEB) would review the pharmaceutical industry's hold on drug prices and stop it peddling mediocre medicines.
    Similar news · Read more »
  6. Translating form into function
    07-01-2007 · EurekAlert!
    In the last 40 years, scientists have perfected ways to determine the knot-like structure of enzymes, but they've been stumped trying to translate the structure into an understanding of function -- what the enzyme actually does in the body. This puzzle has hurt drug discovery, since many of the most successful drugs work by blocking enzyme action. Now, in an expedited article in Nature, researchers show that a solution to the puzzle is finally in sight.
    Similar news · Read more »
  7. Tequila raw ingredient being developed into drug-carrier that targets colon diseases
    03-27-2007 · EurekAlert!
    Compounds derived from the blue agave, a fruit used to make tequila, show promise as a natural, more effective way to deliver drugs to the colon than conventional drug-carriers, according to chemists at the University of Guadalajara in Mexico. The discovery could lead to improved treatments for a variety of colon diseases, including ulcerative colitis, irritable bowel and cancer, they say. The research will be presented in March at the American Chemical Society national meeting.
    Similar news · Read more »
  8. Unstable leukemia stem cells may predispose patients to drug resistance
    05-01-2007 · EurekAlert!
    The BCR-ABL gene in chronic myeloid leukemia stem cells has a tendency to quickly mutate, and this may help explain why patients are predisposed to resistance to drugs like imatinib that target that gene, according to a study in the May 2 Journal of the National Cancer Institute.
    Similar news · Read more »
  9. Split the difference: Pill-splitting study looks at cost-saving step that could be used by millions
    06-11-2007 · EurekAlert!
    Slicing certain pills in half could slice a hefty amount off of Americas prescription drug costs. While only some types of pills can be split safely, they include popular cholesterol-lowering drugs. Now, the first prospective randomized controlled trial of pill-splitting gives more evidence of how the practice could be used.
    Similar news · Read more »
  10. Virtual human in HIV drug simulation
    01-29-2008 · EurekAlert!
    The combined supercomputing power of the UK and US 'national grids' has enabled UCL scientists to simulate the efficacy of an HIV drug in blocking a key protein used by the lethal virus. The method -- an early example of the Virtual Physiological Human in action -- could one day be used to tailor personal drug treatments, for example for HIV patients developing resistance to their drugs.
    Similar news · Read more »